We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Microfluidic Device Could Improve Biomarker Analyses

By LabMedica International staff writers
Posted on 08 Jul 2014
Print article
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria.

The physical attributes of cells are important biomarkers in medicine, whether extracting circulating tumor cells from the blood of a cancer patient, or to measure the elasticity of red blood cells due to malaria infection.

Scientists at The Royal Institute of Technology (KTH; Stockholm, Sweden) proposed a microfluidic device that can sort elastic capsules by their deformability. The device consists of a duct embedded with a semi-cylindrical obstacle, and a diffuser which further enhances the sorting capability. The KTH team used extensive computational simulations to model a microfluidic device that would sort cells according to their elasticity. The work draws on numerical techniques and computational capabilities developed in the last decade to handle the complexity of microscale flows.

Most cell sorting techniques rely on the difference between chemical properties of the cells. The problem is chemical properties do not give pathologists the full picture. Two cells can have very similar chemical properties, but different physical properties. Size, shape and elasticity, or deformability, are important attributes that can be also enable cell sorting, given the right kind of device.

The scientists demonstrated that the device can operate reasonably well under changes in the initial position of the capsule. The efficiency of the device remains essentially unaltered under small changes of the obstacle shape from semicircular to semi-elliptic cross-section. Confinement along the direction perpendicular to the plane of the device increases its efficiency. This work is the first numerical study of cell sorting by a realistic microfluidic device.

Dhrubaditya Mitra, PhD, an assistant professor in theoretical physics and a coauthor of the study offers an example of why elasticity matters. “If you are infected with malaria, the physical nature of your red blood cells changes. They become harder and red blood cells also become harder as they get older too. These harder red blood cells are filtered by the spleen which acts like a sieve. The softer red blood cells can squeeze through the gaps but the harder ones cannot.” The study was published on June 20, 2014, in the journal Soft Matter.

Related Links:

The Royal Institute of Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.